[HTML][HTML] Staphylococcus aureus host interactions and adaptation
BP Howden, SG Giulieri, T Wong Fok Lung… - Nature Reviews …, 2023 - nature.com
Invasive Staphylococcus aureus infections are common, causing high mortality,
compounded by the propensity of the bacterium to develop drug resistance. S. aureus is an …
compounded by the propensity of the bacterium to develop drug resistance. S. aureus is an …
[HTML][HTML] Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
C Duan, M Yu, J Xu, BY Li, Y Zhao… - Biomedicine & …, 2023 - Elsevier
Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …
[HTML][HTML] Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme
A Sosinsky, J Ambrose, W Cross, C Turnbull… - Nature Medicine, 2024 - nature.com
Abstract The Cancer Programme of the 100,000 Genomes Project was an initiative to
provide whole-genome sequencing (WGS) for patients with cancer, evaluating opportunities …
provide whole-genome sequencing (WGS) for patients with cancer, evaluating opportunities …
[HTML][HTML] Big data in basic and translational cancer research
Historically, the primary focus of cancer research has been molecular and clinical studies of
a few essential pathways and genes. Recent years have seen the rapid accumulation of …
a few essential pathways and genes. Recent years have seen the rapid accumulation of …
[HTML][HTML] Access and quality of biomarker testing for precision oncology in Europe
N Normanno, K Apostolidis, A Wolf, R Al Dieri… - European journal of …, 2022 - Elsevier
Background Predictive biomarkers are essential for selecting the best therapeutic strategy in
patients with cancer. The International Quality Network for Pathology, the European Cancer …
patients with cancer. The International Quality Network for Pathology, the European Cancer …
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
Metastatic relapse after treatment is the leading cause of cancer mortality, and known
resistance mechanisms are missing for most treatments administered to patients. To bridge …
resistance mechanisms are missing for most treatments administered to patients. To bridge …
[HTML][HTML] Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: opportunities for integration and pitfalls to interpretation
Plasma circulating tumor DNA (ctDNA) represents short fragments of tumor-derived DNA
released into the bloodstream primarily from cancer cells undergoing apoptosis. In …
released into the bloodstream primarily from cancer cells undergoing apoptosis. In …
Nanozyme-enhanced ferroptosis for cancer treatment
Y Ming, M Huang, Y Huang, D Liu, M Sun… - Materials Chemistry …, 2024 - pubs.rsc.org
Ferroptosis is a programmed, iron-dependent, oxidative cell death that was discovered
recently. It is usually accompanied by iron accumulation and lipid peroxidation during the …
recently. It is usually accompanied by iron accumulation and lipid peroxidation during the …
[HTML][HTML] New clinical trial design in precision medicine: discovery, development and direction
XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …
certain disease are complex and different from each other. Due to the underestimation of the …
[HTML][HTML] Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration
ES Tsang, V Csizmok, LM Williamson… - NPJ Precision …, 2023 - nature.com
There is emerging evidence about the predictive role of homologous recombination
deficiency (HRD), but this is less defined in gastrointestinal (GI) and thoracic malignancies …
deficiency (HRD), but this is less defined in gastrointestinal (GI) and thoracic malignancies …